| Summary |
In 1995, the U.S. Public Health Service (USPHS) and the Infectious Diseases Society of America (IDSA) developed guidelines for preventing opportunistic infections (OIs) in persons infected with human immunodeficiency virus (HIV) (1-3). These guidelines, written for health-care providers and patients, were revised in 1997 (4) and again in 1999 (5), and have been published in the MMWR (1,4,5), Clinical Infectious Diseases (2,6,7), the Annals of Internal Medicine (3,8), the American Family Physician (9,10), and Pediatrics (11) accompanying editorials have appeared in JAMA (12,13). Response to these guidelines (e.g., the many requests for reprints, numerous web site contacts, and observations
from health-care providers) suggests they have served as a valuable reference for HIV care providers. Because the 1995, 1997, and 1999 guidelines included ratings indicating the strength of each recommendation and the quality of supporting evidence, readers have been able to assess the relative importance of each recommendation. |
| More Details |
|
| Publication Webpage |
|
| |
|
| Keywords |
This Item is associated with the Following
Keywords: ARV Treatment Monitor, clinical therapeutic information. |
| |
|
Publications
